Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 50%
Negative

Positive
Zacks Investment Research
1 day ago
SBS or AWR: Which Is the Better Value Stock Right Now?
Investors interested in Utility - Water Supply stocks are likely familiar with Sabesp (SBS) and American States Water (AWR). But which of these two stocks is more attractive to value investors?
SBS or AWR: Which Is the Better Value Stock Right Now?
Neutral
MarketBeat
19 days ago
Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp Q1 Earnings Call Highlights
Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp NYSE: SBS reported higher first-quarter 2026 revenue, EBITDA and net income, while management said the company continued to accelerate investments tied to its universal access commitments and operational transformation.
Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp Q1 Earnings Call Highlights
Positive
Zacks Investment Research
19 days ago
SBS vs. AWR: Which Stock Is the Better Value Option?
Investors interested in Utility - Water Supply stocks are likely familiar with Sabesp (SBS) and American States Water (AWR). But which of these two stocks presents investors with the better value opportunity right now?
SBS vs. AWR: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
21 days ago
4 Stocks to Watch From the Challenging Water Supply Industry
Water utilities like SBS, AWR, AWK and CWT are supported by strategic capital investment plans and strong customer bases, positioning them to outperform peers despite persistent challenges facing the water industry.
4 Stocks to Watch From the Challenging Water Supply Industry
Neutral
Seeking Alpha
22 days ago
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript
Neutral
MarketBeat
22 days ago
Stratec Q1 Earnings Call Highlights
Stratec ETR: SBS reported a soft start to fiscal 2026, with first-quarter revenue and adjusted earnings down from the prior-year period, but management reaffirmed its full-year guidance and said visibility into second-half demand has improved.
Stratec Q1 Earnings Call Highlights
Neutral
Business Wire
1 month ago
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced today that the company will present data from its LANDMARK survey during the 2026 Digestive Disease Week® (DDW) meeting being held from May 2-5 in Chicago, IL. The data will spotlight healthcare professional (HCP) insights on the burden of total parenteral nutrition (TPN) f.
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
Neutral
Business Wire
1 month ago
Stella Legal Unites with CSB, Strategic Business Solutions (SBS) To Build Mission Control for Modern Legal Departments
LONDON, NEW YORK & LISBON, Portugal--(BUSINESS WIRE)-- #LegalTech--Stella Legal and SBS unite to launch a tech-first operating model. It optimizes in-house legal departments via data-driven "Performance Intelligence.".
Stella Legal Unites with CSB, Strategic Business Solutions (SBS) To Build Mission Control for Modern Legal Departments
Positive
Seeking Alpha
1 month ago
Sabesp: A New Privatization As An Opportunity!
Sabesp remains a buy, as its potential Copasa acquisition could be a game-changing catalyst, enhancing its investment thesis. SBS's privatization has driven significant efficiency gains, cost reductions, and a record-high EV/EBITDA multiple, reflecting strong management execution. Acquiring a 30% stake in Copasa would add nearly 10% to SBS's EBITDA, with further upside from operational synergies and a possible 27% valuation re-rating.
Sabesp: A New Privatization As An Opportunity!
Neutral
Seeking Alpha
1 month ago
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Analyst/Investor Day Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Analyst/Investor Day Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Analyst/Investor Day Transcript